MD, Thomas Jefferson University
BA, Franklin & Marshall College
favorite icon LinkedIn

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Vega EA, Agudile E, Salirrosas O, Chirban AM, Brauner E, Crocker A, Freeman R, Sorescu GP, Odisio BC, Conrad C. Clinical outcomes and cost of open, laparoscopic, and percutaneous ablation for hepatocellular carcinoma. J Surg Oncol. 2023 Oct; 128(5):812-822.View Related Profiles. PMID: 37395114
  2. Chirban AM, Vega EA, Kutlu OC, Mellado S, Kozyreva O, Zauls AJ, Panettieri E, Salirrosas O, Freeman R, Conrad C. R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. Surg Oncol. 2023 Aug; 49:101961.View Related Profiles. PMID: 37321066; DOI: 10.1016/j.suronc.2023.101961;
  3. Panettieri E, Vega EA, Chirban AM, Salirrosas O, Clancy TE, Malek A, Freeman R, Conrad C. Anatomic Laparoscopic Partial Hepatectomy of a Segment 4a B-Catenin Mutated Adenoma. Ann Surg Oncol. 2023 Jul; 30(7):4234-4235.View Related Profiles. PMID: 36752966
  4. Mellado S, Vega EA, Abudalou M, Kutlu OC, Salehi O, Li M, Kozyreva O, Freeman R, Conrad C. Trends in Preoperative Chemotherapy Utilization for Proximal Pancreatic Cancer: Are We Making Progress? J Gastrointest Surg. 2022 Aug; 26(8):1-7.View Related Profiles. PMID: 35508681
  5. Salehi O, Vega EA, Mellado S, Core MJ, Li M, Kozyreva O, Kutlu OC, Freeman R, Conrad C. High-Quality Surgery for Gallbladder Carcinoma: Rare, Associated with Disparity, and Not Substitutable by Chemotherapy. J Gastrointest Surg. 2022 Jun; 26(6):1241-1251.View Related Profiles. PMID: 35396641
  6. Vega EA, Mellado S, Salehi O, Freeman R, Conrad C. Treatment of Resectable Gallbladder Cancer. Cancers (Basel). 2022 Mar 10; 14(6).View Related Profiles. PMID: 35326566; PMCID: PMC8945892; DOI: 10.3390/cancers14061413;
  7. Vega EA, Kutlu OC, Salehi O, Alarcon SV, Abudalou M, Kozyreva O, Krishnan S, Lee D, Freeman R, Conrad C. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage. Surg Oncol. 2022 Mar; 40:101694.View Related Profiles. PMID: 34973593; DOI: 10.1016/j.suronc.2021.101694;
  8. Salehi O, Vega EA, Kutlu OC, Lunsford K, Freeman R, Ladin K, Alarcon SV, Kazakova V, Conrad C. Poorly differentiated hepatocellular carcinoma: resection is equivalent to transplantation in patients with low liver fibrosis. HPB (Oxford). 2022 Jul; 24(7):1100-1109.View Related Profiles. PMID: 34969618; DOI: 10.1016/j.hpb.2021.12.001;
  9. Salehi O, Kazakova V, Vega EA, Kutlu OC, Alarcon SV, Freeman R, Kozyreva O, Conrad C. Selection criteria for minimally invasive resection of intrahepatic cholangiocarcinoma-a word of caution: a propensity score matched analysis using the national cancer database. Surg Endosc. 2022 Jul; 36(7):5382-5391.View Related Profiles. PMID: 34750709; DOI: 10.1007/s00464-021-08842-y;
  10. Ruf A, Dirchwolf M, Freeman RB. From Child-Pugh to MELD score and beyond: Taking a walk down memory lane. Ann Hepatol. 2022 Jan-Feb; 27(1):100535. PMID: 34560316; DOI: 10.1016/j.aohep.2021.100535;
Showing 10 of 194 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Contact for Mentoring:

Media Mentions